in the press
Michael G. Palfreyman, Ph.D. joins ActeaVentures as Associate Partner
Boston, MA, May 1st, 2014 - ActeaVentures GmbH is pleased to welcome Michael Palfreyman Ph.D., D.Sc. as Associate Partner. Dr. Palfreyman joins ActeaVentures following a 40 years career within the pharmaceutical and biotech industry in which he held Senior Management positions in R&D and Business Development at Marion Merrell Dow, Scriptgen Pharmaceuticals, Psychiatric Genomics, EnVivo Pharmaceuticals, Chemical Diversity, Amakem and Ophthakem. Most recently he acted as Senior R&D Diligence and Scientific Adviser at Torrey Pines Investment, Inc.. Dr. Palfreyman will head the Boston, MA, office of ActeaVentures. Read full release.
Copyright 2014. All rights reserved.
Vitruvean Drosophila Screening, co-written by Michael Palfreyman